key: cord-0877783-tv228fha
authors: Zbinden‐Foncea, Hermann; Francaux, Marc; Deldicque, Louise; Hawley, John A.
title: Does high cardiorespiratory fitness confer some protection against pro‐inflammatory responses after infection by SARS‐CoV‐2?
date: 2020-04-23
journal: Obesity (Silver Spring)
DOI: 10.1002/oby.22849
sha: 4e3a7c10334e0c9ea426f5c2c409430295e79261
doc_id: 877783
cord_uid: tv228fha

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) originated in China in late 2019 and has since spread rapidly to every continent in the world. This pandemic continues to cause widespread personal suffering, along with severe pressure on medical and health care providers. The symtoms of SARS‐CoV‐2 and the subsequent prognosis is worsened in individuals who have pre‐exisiting comorbidities prior to infection by the virus. Individuals with obesity/overweight, insulin resistance and diabetes typically have chronic low‐grade inflammation characterized by increased levels of several pro‐inflammatory cytokines and the inflammasome: this state predisposes to greater risk for infection along with more adverse outcomes. Here we consider whether a high level of cardiorespiratory fitness induced by prior exercise training may confer some innate immune‐protection against Covid‐19 by attenuating the “cytokine storm syndrome” often experienced by “at risk” individuals.

In December 2019 individuals in Wuhan, the capital city of Hubei province in the People's Republic of China, presented with pneumonia-like symptoms of unknown etiology. Several weeks later the first death attributable to this illness was reported, with the cause confirmed as a novel strain of virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus rapidly spread to every continent causing widespread suffering, panic, social unrest and economic instability. On 20 April 2020 the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University declared that the deadly pandemic (renamed COVID-19 by the World Health Organisation), had infected 2,475,841 people world-wide resulting in 170,261 deaths. The rate of diagnosis and mortality continue to rise, with no viable vaccine currently available. Several factors appear to be associated with an increased risk of hospitalization and mortaility in patients with COVID-19 including advanced age (60 yr), obesity, diabetes, hypertension, cardiovascular disease, a history of smoking and chronic obstructive pulmonary disease (COPD) 1, 2 . Common to these conditions is a state of chronic low-grade inflammation. It has recently been suggested that the world is facing two pandemics simultaneously: [1] the COVID-19 pandemic and [2] a physical inactivity pandemic 3 . Both pandemics cause adverse health effects at the population level, while inflicting widespread burdens on health care systems.

Exercise elicits potent and wide-ranging effects on the immune system, principle amongst these being its anti-inflammatory effects. Indeed, exercise training offers some protection against the development of several chronic metabolic diseases including the insulin resistant state that typically accompanies obesity and diabetes. As such individuals with co-morbidities who have high levels of cardiorespiratory fitness may mount a stronger host immune defense against SARS-CoV-2 and reduce susceptibility to risk of infection in the early stage of the disease. Here, we consider whether high levels of cardiorespiratory fitness induced by prior exercise training may confer some innate immune-protection against Covid-19 by attenuating the "cytokine storm syndrome" often experienced by "at risk" individuals.

This article is protected by copyright. All rights reserved

The progression of COVID-19 is largely dependent on the initial health status of an individual and the immune response triggered by the infection 4 . While susceptibility to infection is multifactorial, epigenetic and environmental/behavioural factors all impact or contribute to immunity in the early stages of the infection. In this incubation phase, the patient does not present with severe symptoms. In order to eliminate the virus, a specific adaptive immune response is required to halt disease progression, and interventional strategies to boost immune responses (or attenuate pro-inflammatory responses) should be of prime consideration. At this time the virus can be asymptomatic, causing no noticeable illness in some individuals, although they remain contagious and can spread infection.

If the protective immune response is impaired or inadequate, the virus will proliferate and destroy affected cells, especially in tissues/organs that have a high expression of angiotensin converting enzyme 2 (ACE2). As a transmembrane protein, ACE2 serves as the main entry point into cells for many coronaviruses, including the SARS-CoV-2 5 . As ACE2 is attached to the outer surface of cells, especially in the lungs, decreasing the levels of ACE2 in cells might help in fighting infection 6 .

During this second phase, the damaged cells induce innate inflammation in the lungs, largely mediated by pro-inflammatory macrophages and granulocytes, which lead to the classic symptoms of fever, coughing, fibrosis and dramatic rise in pro-inflammatory cytokine levels. Lung inflammation is the main cause of life-threatening respiratory disorders at this time.

Proinflammatory cytokines are also elevated in many chronic metabolic diseases such as insulin resistance, obesity and type 2 diabetes 7 , but with a different order of magnitude. Indeed, chronic inflammation is an underlying pathological condition in which inflammatory cells such as neutrophils and monocyte/macrophages infiltrate into fat and other tissues and accumulate in individuals with chronic metabolic conditions. In this regard, recent evidence suggests that individuals with obesity and diabetes are at increased risk for complications from the SARS-CoV-2, including death 8 . Indeed, patients with obesity who are infected with the SARS-CoV-2 have a higher prevalence of invasive mechanical ventilation use, with disease severity strongly associated with a

This article is protected by copyright. All rights reserved higher body mass index (BMI) 9 . The high incidence of diabetes throughout the world and particularly in the elderly make this a major concern as the COVID-19 pandemic spreads.

The calm before the storm: cytokine storm syndrome, lung damage, and fatal respiratory complications A subgroup of patients with severe COVID-19 experience "cytokine storm syndrome" 10 , referring to the overproduction of immune cells and cytokines which are associated with a surge of activated immune cells into the lungs, usually 7-10 days following the onset of symptoms 11 . In health, cytokines and chemokines play important roles in immunity and immunopathology, but dysregulated and amplified immune responses in patients infected with the SARS-CoV-2 are causative of severe lung damage, respiratory complications and reduced rates of survival. In these patients, interleukin (IL)-6, IL-10 and tumor necrosis factor-alpha (TNFα) surge coincidental with peak adverse clinical symptoms, rapidly declining during recovery. Patients requiring intensive care unit (ICU) admission have significantly higher levels of IL-6, IL-10 and TNFα and fewer T cells 12 . This cytokine storm likely dampens innate adaptive immunity against SARS-CoV-2 infection.

The precise mechanisms by which the levels of pro-inflammatory cytokines are increased in patients with COVID-19 is not known. However, it is believed to be initiated by the binding of SARS-CoV-2 to the ACE2 receptor 13 (Fig. 1) , leading to an increase in the number of inflammasomes and levels of pro-inflammatory factors. Paradoxically, ACE2 is involved in the conversion of angiotensin II (Ang II) to angiotensin 1-7 (Ang1-7), which plays a protective role against hypertension, cardiovascular diseases and diabetes 14 Like many other viruses, SARS-CoV-2 is likely to be recognized by Toll like receptors 2, 3 and 4 (TLR 2, 3 and 4), a family of transmembrane proteins with direct roles in the innate immune system, found in many tissues including skeletal muscle, liver and the lungs. First, proteins such as myeloid Accepted Article differentiation primary response 88 (MyD88) or TIR-domain-containing adapter-inducing interferonβ (TRIF) are recruited to an intracellular TLR domain to initiate two distinct inflammatory pathways 15 . One pathway increases IL1- and inflammasome levels via caspase 1 activation, while the other initiates a phosphorylation cascade that activates key proteins, including tumor growth factor- activated kinase (TAK) and I kappa B kinase (IKK). These in turn increase pro-inflammatory cytokine levels such as IL-6 and TNF via the nuclear factor-kappa B (NF-B), the so-called "master regulator" of inflammation. TLR4 has been implicated in LPS-induced acute lung disease 16 and is likely to mediate some of the harmful effects of COVID-19 in this organ.

Exercise training elicits potent and wide-ranging effects on the immune system: high cardiorespiratory fitness and moderate intensity aerobic exercise training improve immune responses to vaccination, lower chronic low-grade inflammation, and improve various immune markers in several disease states including cancer, HIV, cardiovascular disease, diabetes, cognitive impairment and obesity 17, 18 . Furthermore, exercise training may reduce the risk, duration and severity of viral infections 19 . The cytokine profile induced by exercise is classically anti-inflammatory, comprising marked increases in the levels of several potent anti-inflammatory cytokines such as IL-10, IL-1 receptor antagonist (IL-1ra), and IL-6 20 . The "myokine" IL-6 appears to be the major contributor to the anti-inflammatory effects of exercise 21 , with contracting human skeletal muscles producing and releasing significant amounts of IL-6 into circulation to mobilize energy substrates in a similar manner to stress hormones 21 .

Another mechanism whereby exercise induces an anti-inflammatory response is a downregulation of the expression/activation of pro-inflammatory TLRs 22 . Both an acute bout of aerobic exercise 23 as well as resistance-based training 24 decrease the expression of TLR4 on the surface of monocytes. As circulating monocytes are the precursors to tissue macrophages the exercise-induced decreases in monocyte TLR4 expression may be an important mechanism by which

This article is protected by copyright. All rights reserved the anti-inflammatory effects of exercise are mediated 25, 26 , specifically in patients with chronic lowgrade inflammation, such as obese and/or diabetic patients 27 . In addition to attenuating the production of pro-inflammatory cytokines induced by TLR signalling, exercise stimulates the release of anti-inflammatory cytokines. For instance, the IL-1 family cytokine IL-37, is a natural suppressor of innate inflammation and acquired immunity 28 .

Regular bouts of moderate to vigourous intensity exercise have a direct and positive effects on lung function 18 and help lower the risk of respiratory infections/illness 18 . In an experimental asthma model in mice, aerobic exercise increased the production of the anti-inflammatory IL-10 in response to lung inflammation 29 . A three-week swim training protocol in mice had protective effects against LPS-induced systemic inflammation (as measured by reduced circulating concentrations of TNF, IL-6, and IL-1), and lung inflammation 30 . Similar results were reported after a 4 week treadmill running program 31 . Exposure of rat epithelial alveolar cells to cyclic mechanical stretching increased acetyl-CoA carboxylase (ACC) phosphorylation (a surrogate marker for AMP-activated protein kinase (AMPK) activity), by 50%, suggesting that aerobic exercise has beneficial effects on airway epithelial cells 32 . AMPK inhibits NF-B thereby reducing proinflammatory cytokines in airway epithelial cells 33 . While AMPK activation increases ACE2 phosphorylation and elevates Ang 1-7 in pulmonary endothelium cells 34 , regular moderate intensity exercise favors the conversion of Ang II to Ang 1-7 via ACE2. As such, mice treated with an ACE2 activator and submitted to a four-week endurance training were less susceptible to pulmonary fibrosis induced by bleomycin 35 . Thus, exercise may counteract, at least partially, the detrimental effects of the binding of SARS-CoV-2 to ACE2 receptor, reducing the inflammatory response in the lungs.

Preliminary evidence suggests that the severity of symptoms associated with Covid-19 and the eventual outcome of being infected with this virus are associated with the health status of individuals prior to infection. Among the factors linked to an increased risk of hospitalization and mortaility are overweight/obesity, insulin resistance and diabetes: these lifestyle-related diseases,

This article is protected by copyright. All rights reserved [1] by reducing the expression of the TLRs; [2] by increasing the levels of anti-inflammatory cytokines such as IL-10 and IL-37, which in turn will inhibit the TLR-inflammation pathway and counteract the inflammatory response induced by the inflammasomes; and [3] by activating the AMPK-activated protein kinase (AMPK) in the lung, reducing the inflammatory processes by allowing for the transformation of Ang II to Ang 1-7. 

COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? Prog Cardiovasc Dis

COVID-19 infection: the perspectives on immune responses

Structural basis for the recognition of SARS-CoV-2 by fulllength human ACE2

Understanding of COVID-19 based on current evidence

Inflammation and metabolic disorders

Commentary: COVID-19 in patients with diabetes

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

COVID-19: consider cytokine storm syndromes and immunosuppression

Clinical and immunological features of severe and moderate coronavirus disease 2019

Fighting COVID-19 exhausts T cells

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Angiotensin 1-7: a peptide for preventing and treating metabolic syndrome

Overview of the IL-1 family in innate inflammation and acquired immunity

Accepted Article This article is protected by copyright. All rights reserved 16

Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells

Exercise as medicine -evidence for prescribing exercise as therapy in 26 different chronic diseases

Can exercise affect immune function to increase susceptibility to infection?

Physical activity for immunity protection: Inoculating populations with healthy living medicine in preparation for the next pandemic

The immunomodulating role of exercise in metabolic disease

Muscle as an endocrine organ: focus on muscle-derived interleukin-6

Exhaustive exercise modifies different gene expression profiles and pathways in LPS-stimulated and un-stimulated whole blood cultures

The physiological regulation of toll-like receptor expression and function in humans

Toll-like receptor 4 and CD14 mRNA expression are lower in resistive exercise-trained elderly women

Anti-Inflammatory Effect of Exercise Mediated by Toll-Like Receptor Regulation in Innate Immune Cells -A Review

The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease

Toll like receptor expression induced by exercise in obesity and metabolic syndrome: A systematic review

IL-37 is a fundamental inhibitor of innate immunity

Accepted Article This article is protected by copyright. All rights reserved 29

Physical Exercise Induces Immunoregulation of TREG, M2, and pDCs in a

High-Intensity Exercise Prevents Disturbances in Lung Inflammatory Cytokines and Antioxidant Defenses Induced by Lipopolysaccharide

Aerobic exercise inhibits acute lung injury: from mouse to human evidence Exercise reduced lung injury markers in mouse and in cells

Stretch-induced activation of AMP kinase in the lung requires dystroglycan

Influence of exercise on airway epithelia in cystic fibrosis: a review

AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension

Original Research: ACE2 activator associated with physical exercise potentiates the reduction of pulmonary fibrosis